Enliven Therapeutics (ELVN) Earnings Date & Reports

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELVN is expected to report earnings to rise 20.68% to -45 cents per share on August 19

Enliven Therapeutics ELVN Stock Earnings Reports

Q2'26

Est.

$-0.46

Q1'26

Beat

by $0.06

Q4'25

Missed

by $0.02

Q3'25

Beat

by $0.18

Q2'25

Beat

by $0.06

The last earnings report on May 07 showed earnings per share of -37 cents, beating the estimate of -44 cents. With 312.98K shares outstanding, the current market capitalization sits at 2.41B.

View a ticker or compare two or three

Compare

ELVN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ELVN

A.I. Advisor